US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

2.24

+0.350018.52%

Post-market: 2.18-0.0514-2.30%19:59 EDT

Volume:6.94M

Turnover:14.47M

Market Cap:347.47M

PE:-3.46

High:2.26

Open:1.91

Low:1.79

Close:1.89

Loading ...

Overview Company News Filings

Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale

BUZZ-Humacyte tumbles on planned equity raise

Humacyte Inc - to Use Proceeds for Symvess Commercialization, Pipeline Development, Working Capital

THOMSON REUTERS

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte Inc expected to post a loss of 25 cents a share - Earnings Preview

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research

MT Newswires Live

Humacyte, Trestle Biotherapeutics announce research collaboration

Trestle Bio Announces Research Collaboration With Humacyte

THOMSON REUTERS

Trestle Bio Announces Research Collaboration with Humacyte

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Humacyte Shares Rise After Receiving US Patent for Bioreactor Manufacturing System

MT Newswires Live

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess and Other Bioengineered Tissues

THOMSON REUTERS

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte Is Maintained at Buy by D. Boral Capital

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

When Will Humacyte, Inc. (NASDAQ:HUMA) Breakeven?

Simply Wall St.

Humacyte, Pluristyx Announce Gene Editing Partnership

MT Newswires Live

Humacyte, Pluristyx announce expanded partnership

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HUMA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HUMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HUMA\",,,,,undefined,":{"symbol":"HUMA","market":"US","secType":"STK","nameCN":"Humacyte, Inc.","latestPrice":2.24,"timestamp":1747425600000,"preClose":1.89,"halted":0,"volume":6939575,"hourTrading":{"tag":"盘后","latestPrice":2.1799,"preClose":2.231331,"latestTime":"19:59 EDT","volume":114707,"amount":252314.9184,"timestamp":1747439994694},"delay":0,"floatShares":121934449,"shares":155118816,"eps":-0.647002,"marketStatus":"Not Yet Opened","change":0.35,"latestTime":"05-16 16:00:00 EDT","open":1.91,"high":2.26,"low":1.7903,"amount":14472978.454197,"amplitude":0.248519,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.647002,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":1.89,"preHourTrading":{"tag":"盘前","latestPrice":1.93,"preClose":1.89,"latestTime":"09:27 EDT","volume":7590,"amount":14463.581418,"timestamp":1747402046880},"postHourTrading":{"tag":"盘后","latestPrice":2.1799,"preClose":2.231331,"latestTime":"19:59 EDT","volume":114707,"amount":252314.9184,"timestamp":1747439994694},"volumeRatio":0.9922422493429118,"impliedVol":1.3047,"impliedVolPercentile":0.404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HUMA\",,,,,undefined,":{"symbol":"HUMA","floatShares":121934449,"roa":"-42.82%","roe":"-249.75%","lyrEps":-1.255082,"volumeRatio":0.9922422493429118,"shares":155118816,"dividePrice":0,"high":2.26,"amplitude":0.248519,"preClose":1.89,"low":1.7903,"week52Low":1.15,"pbRate":"9.64","psRate":"672.08","week52High":9.97,"institutionHeld":0,"latestPrice":2.24,"eps":-0.647002,"divideRate":0,"volume":6939575,"delay":0,"ttmEps":-0.647002,"open":1.91,"prevYearClose":5.05,"prevWeekClose":1.19,"prevMonthClose":1.45,"prevQuarterClose":1.705,"fiveDayClose":1.19,"twentyDayClose":1.68,"sixtyDayClose":3.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HUMA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522039839","title":"Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2522039839","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522039839?lang=en_us&edition=fundamental","pubTime":"2025-03-26 06:15","pubTimestamp":1742940900,"startTime":"0","endTime":"0","summary":"Shares of Humacyte fell in post-market trading after the company said it was selling additional shares of its common stock.The biotechnology company's shares were down 20% to $2.31 following the close, putting them below the 52-week low of $2.75 set on March 13. The stock ended the market session down 13% at $2.87.Proceeds from the offering are slated to fund the commercialization of Symvess in the vascular trauma indication, development of product candidates in the company's pipeline, and for working capital and general corporate purposes, the company said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4139","BK4563"],"gpt_icon":0},{"id":"2522880655","title":"BUZZ-Humacyte tumbles on planned equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2522880655","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522880655?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:21","pubTimestamp":1742934065,"startTime":"0","endTime":"0","summary":"BUZZ-Humacyte tumbles on planned equity raise**  Shares of biotech firm Humacyte HUMA.O down 23.5% to $2.20 post-market after stock offering news** Durham, North Carolina-based firm announces proposed stock offering without disclosing deal size** Co intends to use net offering proceeds to fund commercialization of its implant Symvess for patients with extreme blood vessel injury** TD Cowen, Barclays and BTIG jt bookrunners** With ~122.65 mln shares outstanding, co has ~$353 mln market cap, per LSEG data** HUMA shares finished Tuesday's session down 13.4% at $2.88. YTD, stock down 43%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL6N3Q80PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","HUMA"],"gpt_icon":0},{"id":"2522887510","title":"Humacyte Inc - to Use Proceeds for Symvess Commercialization, Pipeline Development, Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887510?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:01","pubTimestamp":1742932860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA68Z78F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2522875178","title":"Humacyte, Inc. Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875178?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:01","pubTimestamp":1742932860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA68Z78F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2522959880","title":"Humacyte, Inc. Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522959880","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522959880?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:01","pubTimestamp":1742932860,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., March 25, 2025  -- Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has commenced an underwritten public offering of its common stock. In addition, Humacyte intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the number of shares of common stock sold in connection with the offering. All of the shares are being offered by Humacyte.TD Cowen, Barclays and BTIG are acting as joint book-running managers for the offering. H.C. Wainwright & Co. and The Benchmark Company are acting as lead managers for the offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-inc-announces-proposed-public-200100797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HUMA","USA","HUMAW","BK4563"],"gpt_icon":0},{"id":"2521883281","title":"Humacyte Inc  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521883281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521883281?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:08","pubTimestamp":1742562499,"startTime":"0","endTime":"0","summary":"Humacyte Inc  expected to post a loss of25cents a share - Earnings Preview Humacyte Inc HUMA.OQ HUMA.O is expected to show a rise in quarterly revenue when it reports  results on March 24 (estimated) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q4164:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA"],"gpt_icon":1},{"id":"2518228283","title":"Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics","url":"https://stock-news.laohu8.com/highlight/detail?id=2518228283","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518228283?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:00","pubTimestamp":1741608000,"startTime":"0","endTime":"0","summary":"– Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair –。– Publication of the Budget Impact Model in peer-reviewed journal supports Symvess as a treatment that provides economic value to hospitals and payers –。“Demonstrating economic value to the health care system is the next major step in the successful commercialization of Symvess and complements the recent publication of efficacy and safety result in JAMA Surgery,” said Laura Niklason, M.D., Ph.D., Founder and Chief Executive Officer of Humacyte. “The economic modeling described in this peer-reviewed publication confirms that the avoidance of vascular infections and amputations to be strong opportunities for cost reduction with the use of Symvess in this patient population. Economic models are employed by health care decision-makers to more fully understand the financial implications of a product given its expected clinical perfor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-announces-publication-budget-impact-120000090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HUMA","BK4563","HUMAW"],"gpt_icon":0},{"id":"2517716877","title":"Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517716877?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:15","pubTimestamp":1741270501,"startTime":"0","endTime":"0","summary":"Humacyte , a commercial-stage company, will collaborate with preclinical-stage firm Trestle Biotherapeutics to explore technology synergies for bioengineering vascularized organs for transplantation, Trestle Biotherapeutics said Thursday.Trestle Bio said the research allows both companies to expand their own R&D programs while looking into the interaction of Trestle Bio's biofabricated human kidney tissues with Humacyte's acellular tissue engineered vessel-tyod.Financial terms of the collaboration were not disclosed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2517152208","title":"Humacyte, Trestle Biotherapeutics announce research collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152208","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517152208?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:12","pubTimestamp":1741266723,"startTime":"0","endTime":"0","summary":"Trestle Biotherapeutics announced a research collaboration with Humacyte (HUMA). The collaboration will explore technology synergies for bioenginee...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/humacyte-trestle-biotherapeutics-announce-research-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/humacyte-trestle-biotherapeutics-announce-research-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HUMA","BK4563","BK4139"],"gpt_icon":0},{"id":"2517154917","title":"Trestle Bio Announces Research Collaboration With Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154917","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154917?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUAZRTQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HUMA","BK4563","BK4139"],"gpt_icon":0},{"id":"2517520001","title":"Trestle Bio Announces Research Collaboration with Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2517520001","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517520001?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 06, 2025----Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale. Trestle Bio is a preclinical stage company developing bioengineered kidney tissues for patients suffering from end stage renal disease . The collaboration will explore technology synergies for bioengineering vascularized organs for transplantation.The aim of the recently announced research collaboration and material transfer agreement is for the two companies to explore potential avenues of technology integration. The collaboration offers both groups the opportunity to expand their own R&D programs while exploring the interaction of Trestle Bio’s biofabricated human kidney tissues with Humacyte’s acelluar tissue engineered vessel-tyod , with a goal of generating a human bioengineered kidney with vascular perfusion.Ben Shepherd Ph.D.,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trestle-bio-announces-research-collaboration-130000083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMAW","HUMA"],"gpt_icon":0},{"id":"2516331906","title":"Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516331906","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516331906?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., March 03, 2025  -- Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced it will host an in-person and virtual investor event in New York on Thursday, March 6, 2025 at 12:00 PM ET. To register as an in-person or virtual attendee, please click here.The event will feature vascular surgery key opinion leaders  Michael Curi, MD, MPA  and Sammy Siada, DO, FACS, RPVI , who will join company management to discuss the commercial plans and early market-launch success of Symvess  for extremity arterial injury.Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair. The U.S. Food and Drug Administration  granted a full approval for Symvess in December 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-host-person-virtual-investor-130000973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HST","BK4585","HUMAW","BK4588","BK4181","HUMA","BK4218"],"gpt_icon":0},{"id":"2514336799","title":"Humacyte Shares Rise After Receiving US Patent for Bioreactor Manufacturing System","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336799","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514336799?lang=en_us&edition=fundamental","pubTime":"2025-02-28 02:43","pubTimestamp":1740681829,"startTime":"0","endTime":"0","summary":"Humacyte  shares were up over 5% in recent Thursday trading after the company said it received a US patent covering \"key aspects\" of its bioreactor manufacturing system.The company said its Symvess acellular tissue-engineered vessel, designed for arterial replacement and repair, is manufactured using the patented system.The patent lasts until 2040, according to the company.Price: 3.61, Change: +0.18, Percent Change: +5.10","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4563","HUMA"],"gpt_icon":0},{"id":"2514804183","title":"Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess and Other Bioengineered Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804183?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:07","pubTimestamp":1740661636,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI1BO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2514804593","title":"Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804593?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"– Patent provides coverage into 2040 for key aspects of the bioreactor manufacturing system–。DURHAM, N.C., Feb. 27, 2025  -- Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the issuance of a U.S. Patent covering key aspects of the manufacturing of Symvess  and other bioengineered human tissues. U.S. Patent No. 12,195,711, titled “Drawer System for Cultivating Tissue,” covers key aspects of the bioreactor system that Humacyte uses to manufacture bioengineered human tissues. The newly issued patent provides protection into 2040. The new patent complements a family of existing patents and patent applications encompassing the design and composition of Humacyte’s products, and their methods of manufacture.Humacyte, Inc.  is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-announces-issuance-u-patent-130000002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMA","HUMAW"],"gpt_icon":0},{"id":"2514394858","title":"Humacyte Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2514394858","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514394858?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:37","pubTimestamp":1740577020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HUMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2025 08:37 ET (13:37 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA"],"gpt_icon":0},{"id":"2514832092","title":"Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514832092","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514832092?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"– The FDA has authorized Humacyte to release commercial shipments –。– Positive responses from surgeons and trauma centers to initial sales and marketing outreach –。- 21 hospitals have already initiated the Value Analysis Committee  approval process –。Symvess, or the ATEV , is a first-in-class bioengineered human tissue that is designed to be a universally implantable vascular conduit for use in arterial replacement and repair. In clinical studies, Symvess has been utilized by vascular and trauma surgeons in Level 1 Trauma centers throughout the U.S. and Israel to repair severe limb-threatening and life-threatening injuries, and in front-line hospitals in Ukraine to treat wartime injuries. In contrast to harvesting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-announces-commercial-launch-symvess-130000682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VAC","BK4142","HUMA","BK4563","LU0053671581.USD","HUMAW"],"gpt_icon":1},{"id":"2512634103","title":"When Will Humacyte, Inc. (NASDAQ:HUMA) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512634103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512634103?lang=en_us&edition=fundamental","pubTime":"2025-02-19 19:24","pubTimestamp":1739964273,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Humacyte, Inc.'s  business as it appears the company may be on the cusp of a considerable accomplishment. Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The US$503m market-cap company posted a loss in its most recent financial year of US$111m and a latest trailing-twelve-month loss of US$153m leading to an even wider gap between loss and breakeven. As path to profitability is the topic on Humacyte's investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Humacyte’s board and the CEO’s background.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-inc-nasdaq-huma-breakeven-112433376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMA","NDAQ","IE00BKPKM429.USD","HUMAW","LU2210149790.SGD","BK4139","USJW.SI","SQQQ","TQQQ","USAW.SI","IE00BGHQF748.EUR","TSYW.SI","IE00B3QW5Z07.USD","NQmain","NVIW.SI","BK4112","MNQmain","LU2095319765.USD","QLD","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD",".IXIC","BK4585","PSQ","BK4563","QQQ","QID"],"gpt_icon":1},{"id":"2507154529","title":"Humacyte, Pluristyx Announce Gene Editing Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2507154529","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507154529?lang=en_us&edition=fundamental","pubTime":"2025-01-29 01:04","pubTimestamp":1738083840,"startTime":"0","endTime":"0","summary":"Humacyte  and closely held Pluristyx expanded their partnership to include gene editing to support Humacyte's development of its investigational BioVascular Pancreas using cell lines provided by Pluristyx.Humacyte's BVP is designed to treat insulin-dependent diabetes.The expanded partnership builds on Humacyte's existing license of Pluristyx's PluriBank cell lines, the companies said Tuesday in a statement.Price: 4.50, Change: -0.01, Percent Change: -0.22","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4563","HUMA"],"gpt_icon":0},{"id":"2506154785","title":"Humacyte, Pluristyx announce expanded partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2506154785","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506154785?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:27","pubTimestamp":1738070821,"startTime":"0","endTime":"0","summary":"Humacyte (HUMA) and Pluristyx announced an expanded partnership. Pluristyx makes and sells PluriBank iPSC lines as part of their tools, technologie...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/humacyte-pluristyx-announce-expanded-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/humacyte-pluristyx-announce-expanded-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HUMA","BK4139","BK4563"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":98,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HUMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"HUMA","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-03-28","symbol":"HUMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2024-11-08","symbol":"HUMA","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-08-13","symbol":"HUMA","fiscalQuarterEnding":"2024/06","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2024-05-10","symbol":"HUMA","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HUMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HUMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.7143,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1725940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HUMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HUMA","date":"2025-05-16","current":-3.774812,"percent":0.60989,"low":-42.920684,"twenty":-13.703315,"median":-4.672091,"eighty":-1.683404,"high":18.870018,"avg":-5.97188,"sd":10.434869,"marketCap":293174562},"quantilePoints":[{"date":"2021-08-27","current":-18.172424,"twenty":-17.803017,"median":-17.248908,"eighty":-16.694798,"marketCap":1256641284},{"date":"2021-09-03","current":-19.946088,"twenty":-22.569056,"median":-19.946088,"eighty":-18.371508,"marketCap":1425566834},{"date":"2021-09-10","current":-20.003735,"twenty":-21.070217,"median":-19.946088,"eighty":-18.749899,"marketCap":1429686969},{"date":"2021-09-17","current":-20.609036,"twenty":-22.511408,"median":-20.126237,"eighty":-19.167844,"marketCap":1472948391},{"date":"2021-09-24","current":-18.086951,"twenty":-21.070217,"median":-20.003735,"eighty":-18.749899,"marketCap":1292692469},{"date":"2021-10-01","current":-15.89634,"twenty":-20.609036,"median":-19.881234,"eighty":-18.086951,"marketCap":1136127325},{"date":"2021-10-08","current":-15.838692,"twenty":-20.479328,"median":-19.095785,"eighty":-16.325391,"marketCap":1132007190},{"date":"2021-10-15","current":-14.728975,"twenty":-20.133443,"median":-18.288218,"eighty":-15.305452,"marketCap":1052694584},{"date":"2021-10-22","current":-13.979556,"twenty":-20.133443,"median":-18.086951,"eighty":-14.728975,"marketCap":999132824},{"date":"2021-10-29","current":-13.114841,"twenty":-20.119031,"median":-16.970028,"eighty":-14.339854,"marketCap":937330794},{"date":"2021-11-05","current":-15.507218,"twenty":-20.003735,"median":-15.953988,"eighty":-14.411913,"marketCap":1108316411},{"date":"2021-11-12","current":-14.930742,"twenty":-19.9605,"median":-15.766633,"eighty":-14.411913,"marketCap":1067115058},{"date":"2021-11-19","current":-13.226623,"twenty":-19.946088,"median":-15.507218,"eighty":-14.181322,"marketCap":1127887054},{"date":"2021-11-26","current":-13.26286,"twenty":-19.842322,"median":-15.334276,"eighty":-14.005323,"marketCap":1130977156},{"date":"2021-12-03","current":-12.550193,"twenty":-19.297551,"median":-15.204569,"eighty":-13.340166,"marketCap":1070205159},{"date":"2021-12-10","current":-12.308611,"twenty":-19.110197,"median":-14.959566,"eighty":-13.111959,"marketCap":1049604482},{"date":"2021-12-17","current":-10.520903,"twenty":-18.819076,"median":-14.829859,"eighty":-12.791775,"marketCap":897159474},{"date":"2021-12-23","current":-9.373388,"twenty":-18.542367,"median":-14.476767,"eighty":-12.594979,"marketCap":799306259},{"date":"2021-12-31","current":-8.757353,"twenty":-18.26506,"median":-14.411913,"eighty":-12.468055,"marketCap":746774534},{"date":"2022-01-07","current":-7.549442,"twenty":-18.12114,"median":-14.267794,"eighty":-12.199899,"marketCap":643771150},{"date":"2022-01-14","current":-7.04212,"twenty":-18.086951,"median":-14.152499,"eighty":-10.520903,"marketCap":600509728},{"date":"2022-01-21","current":-6.305294,"twenty":-18.075421,"median":-14.011765,"eighty":-9.520753,"marketCap":537677664},{"date":"2022-01-28","current":-5.616785,"twenty":-17.718006,"median":-13.878895,"eighty":-9.112479,"marketCap":478965735},{"date":"2022-02-04","current":-6.305294,"twenty":-17.017587,"median":-13.26286,"eighty":-8.757353,"marketCap":537677664},{"date":"2022-02-11","current":-6.691826,"twenty":-16.569495,"median":-13.164693,"eighty":-7.445562,"marketCap":570638747},{"date":"2022-02-18","current":-6.486481,"twenty":-16.17683,"median":-13.081674,"eighty":-7.131506,"marketCap":553128172},{"date":"2022-02-25","current":-6.933408,"twenty":-15.942458,"median":-12.803854,"eighty":-6.964813,"marketCap":591239424},{"date":"2022-03-04","current":-6.534797,"twenty":-15.88481,"median":-12.666028,"eighty":-6.93824,"marketCap":557248307},{"date":"2022-03-11","current":-6.873012,"twenty":-15.809868,"median":-12.509541,"eighty":-6.885091,"marketCap":586089254},{"date":"2022-03-18","current":-7.71855,"twenty":-15.668632,"median":-12.465639,"eighty":-6.875428,"marketCap":658191623},{"date":"2022-03-25","current":-7.791025,"twenty":-15.553336,"median":-12.260294,"eighty":-6.885091,"marketCap":664371826},{"date":"2022-04-01","current":-27.815942,"twenty":-15.88481,"median":-12.381086,"eighty":-6.894754,"marketCap":736482689},{"date":"2022-04-08","current":-25.870771,"twenty":-17.112705,"median":-12.489797,"eighty":-6.93824,"marketCap":684980403},{"date":"2022-04-14","current":-28.671817,"twenty":-18.086951,"median":-12.550193,"eighty":-6.957566,"marketCap":759143695},{"date":"2022-04-22","current":-27.621425,"twenty":-19.095785,"median":-12.72534,"eighty":-6.993803,"marketCap":731332461},{"date":"2022-04-29","current":-27.543618,"twenty":-19.9605,"median":-12.900487,"eighty":-7.04212,"marketCap":729272369},{"date":"2022-05-06","current":-24.431345,"twenty":-20.133443,"median":-13.107635,"eighty":-7.066278,"marketCap":646868712},{"date":"2022-05-13","current":-21.267862,"twenty":-20.479328,"median":-13.226623,"eighty":-7.114594,"marketCap":553134551},{"date":"2022-05-20","current":-18.653935,"twenty":-20.307583,"median":-13.619194,"eighty":-7.126674,"marketCap":485151534},{"date":"2022-05-27","current":-21.782726,"twenty":-20.307583,"median":-13.979556,"eighty":-7.126674,"marketCap":566525146},{"date":"2022-06-03","current":-24.238234,"twenty":-21.109746,"median":-14.123675,"eighty":-7.136337,"marketCap":630387980},{"date":"2022-06-10","current":-16.198427,"twenty":-20.701272,"median":-14.210146,"eighty":-7.167743,"marketCap":421288699},{"date":"2022-06-17","current":-14.851859,"twenty":-20.50527,"median":-14.339854,"eighty":-7.194316,"marketCap":386267145},{"date":"2022-06-24","current":-13.148846,"twenty":-20.376281,"median":-14.257784,"eighty":-7.213643,"marketCap":341975179},{"date":"2022-07-01","current":-13.030031,"twenty":-20.265913,"median":-14.199751,"eighty":-7.259544,"marketCap":338885041},{"date":"2022-07-08","current":-14.099365,"twenty":-20.196257,"median":-14.166911,"eighty":-7.288534,"marketCap":366696276},{"date":"2022-07-15","current":-13.861735,"twenty":-20.133443,"median":-14.099365,"eighty":-7.319939,"marketCap":360516002},{"date":"2022-07-22","current":-13.643908,"twenty":-20.127678,"median":-14.01596,"eighty":-7.389998,"marketCap":354850750},{"date":"2022-07-29","current":-13.782525,"twenty":-20.072913,"median":-13.940945,"eighty":-7.445562,"marketCap":358455910},{"date":"2022-08-05","current":-13.861735,"twenty":-19.986441,"median":-13.870315,"eighty":-7.491463,"marketCap":360516002},{"date":"2022-08-12","current":16.960989,"twenty":-19.954735,"median":-13.861735,"eighty":-7.491463,"marketCap":475891429},{"date":"2022-08-19","current":16.520444,"twenty":-19.894205,"median":-13.861735,"eighty":-7.288534,"marketCap":463530613},{"date":"2022-08-26","current":15.382369,"twenty":-19.748318,"median":-13.82213,"eighty":-7.153248,"marketCap":431598504},{"date":"2022-09-02","current":16.006474,"twenty":-19.630663,"median":-13.802328,"eighty":-7.085604,"marketCap":449109661},{"date":"2022-09-09","current":16.557156,"twenty":-19.598827,"median":-13.762722,"eighty":-6.964813,"marketCap":464560681},{"date":"2022-09-16","current":14.501278,"twenty":-19.485448,"median":-13.703315,"eighty":-6.875428,"marketCap":406876871},{"date":"2022-09-23","current":12.812522,"twenty":-19.153432,"median":-13.634006,"eighty":-6.815033,"marketCap":359493742},{"date":"2022-09-30","current":11.968144,"twenty":-19.04702,"median":-13.5845,"eighty":-6.682163,"marketCap":335802177},{"date":"2022-10-07","current":11.527599,"twenty":-18.844038,"median":-13.406278,"eighty":-6.546876,"marketCap":323441361},{"date":"2022-10-14","current":11.564311,"twenty":-18.804434,"median":-13.359493,"eighty":-6.486481,"marketCap":324471429},{"date":"2022-10-21","current":12.261841,"twenty":-18.76818,"median":-13.244741,"eighty":-6.356027,"marketCap":344042722},{"date":"2022-10-28","current":13.069507,"twenty":-18.746548,"median":-13.188451,"eighty":-6.102365,"marketCap":366704218},{"date":"2022-11-04","current":12.07828,"twenty":-18.717303,"median":-13.107635,"eighty":-5.682012,"marketCap":338892381},{"date":"2022-11-11","current":9.639204,"twenty":-18.638093,"median":-13.030031,"eighty":11.527599,"marketCap":331010259},{"date":"2022-11-18","current":8.798401,"twenty":-18.540583,"median":-12.798127,"eighty":11.179949,"marketCap":302137090},{"date":"2022-11-25","current":9.519089,"twenty":-18.404013,"median":-12.728325,"eighty":9.819376,"marketCap":326885521},{"date":"2022-12-02","current":9.459032,"twenty":-18.337095,"median":-12.624836,"eighty":9.789347,"marketCap":324823152},{"date":"2022-12-09","current":9.008602,"twenty":-18.172424,"median":-12.499669,"eighty":9.72929,"marketCap":309355383},{"date":"2022-12-16","current":7.477139,"twenty":-18.086951,"median":-12.45356,"eighty":9.72929,"marketCap":256764967},{"date":"2022-12-23","current":6.906595,"twenty":-18.086951,"median":-12.242176,"eighty":9.639204,"marketCap":237172460},{"date":"2022-12-30","current":6.33605,"twenty":-18.065278,"median":-11.499311,"eighty":9.615181,"marketCap":217579952},{"date":"2023-01-06","current":6.756451,"twenty":-18.05882,"median":-10.653773,"eighty":9.555123,"marketCap":232016537},{"date":"2023-01-13","current":7.507168,"twenty":-18.035404,"median":-9.808236,"eighty":9.483055,"marketCap":257796152},{"date":"2023-01-20","current":7.537197,"twenty":-17.782625,"median":-9.506258,"eighty":9.459032,"marketCap":258827337},{"date":"2023-01-27","current":8.347971,"twenty":-17.426181,"median":-9.409625,"eighty":9.44702,"marketCap":286669321},{"date":"2023-02-03","current":9.699261,"twenty":-17.338838,"median":-8.79359,"eighty":9.44702,"marketCap":333072629},{"date":"2023-02-10","current":8.648258,"twenty":-17.200115,"median":-8.757353,"eighty":9.459032,"marketCap":296981167},{"date":"2023-02-17","current":9.398974,"twenty":-17.006023,"median":-7.791025,"eighty":9.459032,"marketCap":322760782},{"date":"2023-02-24","current":8.738344,"twenty":-16.650863,"median":-7.778945,"eighty":9.453026,"marketCap":300074721},{"date":"2023-03-03","current":9.429003,"twenty":-16.299998,"median":-7.652115,"eighty":9.429003,"marketCap":323791967},{"date":"2023-03-10","current":8.167799,"twenty":-16.149539,"median":-7.549442,"eighty":9.453026,"marketCap":280482213},{"date":"2023-03-17","current":8.82843,"twenty":-15.942458,"median":-7.398454,"eighty":9.429003,"marketCap":303168275},{"date":"2023-03-24","current":-25.130612,"twenty":-15.942458,"median":-7.295781,"eighty":9.422997,"marketCap":300687777},{"date":"2023-03-31","current":-26.685083,"twenty":-17.097287,"median":-7.44677,"eighty":9.398974,"marketCap":319287020},{"date":"2023-04-06","current":-25.56241,"twenty":-17.426181,"median":-7.555481,"eighty":9.398974,"marketCap":305854233},{"date":"2023-04-14","current":-28.584992,"twenty":-18.086951,"median":-7.694392,"eighty":9.368946,"marketCap":342019430},{"date":"2023-04-21","current":-28.757711,"twenty":-18.404013,"median":-7.784985,"eighty":9.27886,"marketCap":344086012},{"date":"2023-04-28","current":-27.894116,"twenty":-18.749899,"median":-8.141319,"eighty":9.27886,"marketCap":333753099},{"date":"2023-05-05","current":-37.998191,"twenty":-19.095785,"median":-8.775472,"eighty":9.27886,"marketCap":454648352},{"date":"2023-05-12","current":-36.659618,"twenty":-19.646225,"median":-8.93854,"eighty":9.27886,"marketCap":438632330},{"date":"2023-05-19","current":-14.94797,"twenty":-19.607321,"median":-9.451901,"eighty":9.248831,"marketCap":435015809},{"date":"2023-05-26","current":-12.817618,"twenty":-19.564849,"median":-9.542495,"eighty":9.218802,"marketCap":373018307},{"date":"2023-06-02","current":-12.000983,"twenty":-19.247245,"median":-10.520903,"eighty":9.218802,"marketCap":349252597},{"date":"2023-06-09","current":-15.089993,"twenty":-19.110197,"median":-10.810802,"eighty":9.218802,"marketCap":439148976},{"date":"2023-06-16","current":-11.903568,"twenty":-18.900724,"median":-12.000983,"eighty":9.218802,"marketCap":346417630},{"date":"2023-06-23","current":-10.41118,"twenty":-18.828197,"median":-11.441638,"eighty":9.200785,"marketCap":302986166},{"date":"2023-06-30","current":-10.730978,"twenty":-18.796513,"median":-10.786643,"eighty":9.176762,"marketCap":312292908},{"date":"2023-07-07","current":-9.771586,"twenty":-18.76818,"median":-10.730978,"eighty":9.152739,"marketCap":284372682},{"date":"2023-07-14","current":-11.335039,"twenty":-18.746548,"median":-10.659911,"eighty":9.128716,"marketCap":329872311},{"date":"2023-07-21","current":-10.730978,"twenty":-18.717303,"median":-10.766511,"eighty":9.12271,"marketCap":312292908},{"date":"2023-07-28","current":-9.842652,"twenty":-18.638093,"median":-10.677678,"eighty":9.092682,"marketCap":286440846},{"date":"2023-08-04","current":-11.086308,"twenty":-18.540583,"median":-10.730978,"eighty":9.068659,"marketCap":322633733},{"date":"2023-08-11","current":-12.116766,"twenty":-18.390629,"median":-10.766511,"eighty":9.062653,"marketCap":352622125},{"date":"2023-08-18","current":-4.129169,"twenty":-18.304161,"median":-10.730978,"eighty":9.032624,"marketCap":366158154},{"date":"2023-08-25","current":-4.234147,"twenty":-18.155329,"median":-10.624378,"eighty":9.008602,"marketCap":375467260},{"date":"2023-09-01","current":-4.467434,"twenty":-18.086951,"median":-10.520903,"eighty":9.008602,"marketCap":396154161},{"date":"2023-09-08","current":-4.432441,"twenty":-18.086951,"median":-10.41118,"eighty":9.008602,"marketCap":393051126},{"date":"2023-09-15","current":-4.129169,"twenty":-18.05986,"median":-10.322347,"eighty":8.948544,"marketCap":366158154},{"date":"2023-09-22","current":-3.417645,"twenty":-18.058127,"median":-10.269048,"eighty":8.918516,"marketCap":303063105},{"date":"2023-09-29","current":-3.405981,"twenty":-18.020255,"median":-10.215749,"eighty":8.918516,"marketCap":302028760},{"date":"2023-10-06","current":-3.301002,"twenty":-17.426181,"median":-10.091383,"eighty":8.82843,"marketCap":292719654},{"date":"2023-10-13","current":-2.857758,"twenty":-17.426181,"median":-9.878185,"eighty":8.798401,"marketCap":253414542},{"date":"2023-10-20","current":-2.72945,"twenty":-17.207824,"median":-9.771586,"eighty":8.738344,"marketCap":242036746},{"date":"2023-10-27","current":-2.437842,"twenty":-17.200115,"median":-9.542495,"eighty":8.738344,"marketCap":216178119},{"date":"2023-11-03","current":-2.461171,"twenty":-17.006023,"median":-9.451901,"eighty":8.726332,"marketCap":218246809},{"date":"2023-11-10","current":-2.557224,"twenty":-16.569495,"median":-8.93854,"eighty":8.708315,"marketCap":228590260},{"date":"2023-11-17","current":-2.827202,"twenty":-16.274605,"median":-8.775472,"eighty":8.696303,"marketCap":252723624},{"date":"2023-11-24","current":-3.001006,"twenty":-16.149539,"median":-8.449336,"eighty":8.67228,"marketCap":268259913},{"date":"2023-12-01","current":-3.070527,"twenty":-15.942458,"median":-7.791025,"eighty":8.642252,"marketCap":274474428},{"date":"2023-12-08","current":-3.267504,"twenty":-15.88481,"median":-7.706471,"eighty":8.606218,"marketCap":292082221},{"date":"2023-12-15","current":-3.615111,"twenty":-15.809868,"median":-7.561521,"eighty":8.558172,"marketCap":323154798},{"date":"2023-12-22","current":-3.255918,"twenty":-15.668632,"median":-7.44677,"eighty":8.552166,"marketCap":291046469},{"date":"2023-12-29","current":-3.441308,"twenty":-15.590807,"median":-7.356177,"eighty":8.534149,"marketCap":307618510},{"date":"2024-01-05","current":-3.105288,"twenty":-15.541807,"median":-7.289741,"eighty":8.50412,"marketCap":277581686},{"date":"2024-01-12","current":-3.128462,"twenty":-15.484159,"median":-7.199148,"eighty":8.42004,"marketCap":279653191},{"date":"2024-01-19","current":-3.001006,"twenty":-15.426512,"median":-7.138753,"eighty":8.33596,"marketCap":268259913},{"date":"2024-01-26","current":-3.476069,"twenty":-15.332844,"median":-7.120634,"eighty":8.275902,"marketCap":310725768},{"date":"2024-02-02","current":-3.951131,"twenty":-15.322785,"median":-7.04212,"eighty":8.215845,"marketCap":353191622},{"date":"2024-02-09","current":-3.632492,"twenty":-15.293922,"median":-6.945487,"eighty":8.143776,"marketCap":324708427},{"date":"2024-02-16","current":-5.167755,"twenty":-15.246978,"median":-6.885091,"eighty":8.035673,"marketCap":461945641},{"date":"2024-02-23","current":-4.988158,"twenty":-15.243673,"median":-6.848854,"eighty":7.987627,"marketCap":445891477},{"date":"2024-03-01","current":-5.692386,"twenty":-15.208303,"median":-6.818657,"eighty":7.897541,"marketCap":508842363},{"date":"2024-03-08","current":-4.352632,"twenty":-15.196511,"median":-6.703905,"eighty":7.897541,"marketCap":389081787},{"date":"2024-03-15","current":-4.206213,"twenty":-15.161333,"median":-6.661628,"eighty":7.807455,"marketCap":375993408},{"date":"2024-03-22","current":-4.791889,"twenty":-15.089993,"median":-6.595193,"eighty":7.807455,"marketCap":428346921},{"date":"2024-03-28","current":-3.329731,"twenty":-15.02024,"median":-6.534797,"eighty":7.783432,"marketCap":368854293},{"date":"2024-04-05","current":-3.353987,"twenty":-14.9771,"median":-6.486481,"eighty":7.753403,"marketCap":371541231},{"date":"2024-04-12","current":-3.246487,"twenty":-14.961788,"median":-6.389848,"eighty":7.699351,"marketCap":359632858},{"date":"2024-04-19","current":-3.859235,"twenty":-14.950289,"median":-6.329453,"eighty":7.567226,"marketCap":427510583},{"date":"2024-04-26","current":-4.192483,"twenty":-14.934188,"median":-6.208661,"eighty":7.537197,"marketCap":464426539},{"date":"2024-05-03","current":-4.730006,"twenty":-14.930742,"median":-6.069751,"eighty":7.513174,"marketCap":523971153},{"date":"2024-05-10","current":-4.859006,"twenty":-14.867636,"median":-5.692386,"eighty":7.507168,"marketCap":538261275},{"date":"2024-05-17","current":-7.232733,"twenty":-14.851859,"median":-6.003317,"eighty":7.483145,"marketCap":764521546},{"date":"2024-05-24","current":-8.122742,"twenty":-14.843533,"median":-6.075791,"eighty":7.477139,"marketCap":858598185},{"date":"2024-05-31","current":-10.252004,"twenty":-14.773966,"median":-6.208661,"eighty":7.477139,"marketCap":1083667612},{"date":"2024-06-07","current":-8.246667,"twenty":-14.711247,"median":-6.329453,"eighty":7.477139,"marketCap":871697463},{"date":"2024-06-14","current":-8.111476,"twenty":-14.699428,"median":-6.377769,"eighty":7.345013,"marketCap":857407341},{"date":"2024-06-21","current":-5.903352,"twenty":-14.69823,"median":-6.407966,"eighty":7.098778,"marketCap":624002009},{"date":"2024-06-28","current":-5.294991,"twenty":-14.695835,"median":-6.407966,"eighty":7.002687,"marketCap":559696459},{"date":"2024-07-05","current":-6.387787,"twenty":-14.624823,"median":-6.387787,"eighty":6.906595,"marketCap":675208281},{"date":"2024-07-12","current":-7.266531,"twenty":-14.506729,"median":-6.387787,"eighty":6.846537,"marketCap":768094076},{"date":"2024-07-15","current":-7.874891,"twenty":-14.499143,"median":-6.388818,"eighty":6.816509,"marketCap":832399627},{"date":"2024-08-02","current":-9.711239,"twenty":-14.491558,"median":-6.389848,"eighty":6.78648,"marketCap":1026507122},{"date":"2024-08-09","current":-9.012751,"twenty":-14.472443,"median":-6.465299,"eighty":6.66036,"marketCap":952674824},{"date":"2024-08-16","current":-5.247142,"twenty":-14.458031,"median":-6.444117,"eighty":6.600303,"marketCap":732815889},{"date":"2024-08-23","current":-5.469334,"twenty":-14.42056,"median":-6.388818,"eighty":6.55526,"marketCap":763847180},{"date":"2024-08-30","current":-5.255688,"twenty":-14.354266,"median":-6.387787,"eighty":6.450159,"marketCap":734009400},{"date":"2024-09-06","current":-4.683117,"twenty":-14.313912,"median":-6.353611,"eighty":6.372084,"marketCap":654044148},{"date":"2024-09-13","current":-4.802759,"twenty":-14.282662,"median":-6.256977,"eighty":6.33605,"marketCap":670753305},{"date":"2024-09-20","current":-4.65748,"twenty":-14.264014,"median":-6.075791,"eighty":6.33605,"marketCap":650463614},{"date":"2024-09-27","current":-4.674571,"twenty":-14.246496,"median":-6.05676,"eighty":6.281998,"marketCap":652850637},{"date":"2024-10-04","current":-4.512201,"twenty":-14.226496,"median":-6.007722,"eighty":6.209929,"marketCap":630173924},{"date":"2024-10-11","current":-4.96873,"twenty":-14.196065,"median":-5.920251,"eighty":6.113838,"marketCap":693932828},{"date":"2024-10-18","current":-4.350996,"twenty":-14.164028,"median":-5.691526,"eighty":1.033597,"marketCap":607660098},{"date":"2024-10-25","current":-5.210452,"twenty":-14.150452,"median":-5.612421,"eighty":-2.335196,"marketCap":727691722},{"date":"2024-10-31","current":-4.610623,"twenty":-14.138923,"median":-5.533428,"eighty":-2.358525,"marketCap":643919651},{"date":"2024-11-08","current":-4.709103,"twenty":-14.113951,"median":-5.469334,"eighty":-2.402849,"marketCap":657673274},{"date":"2024-11-15","current":-3.984902,"twenty":-14.097951,"median":-5.374398,"eighty":-2.447174,"marketCap":609159960},{"date":"2024-11-22","current":-3.686655,"twenty":-14.065559,"median":-5.294991,"eighty":-2.465837,"marketCap":563567959},{"date":"2024-11-29","current":-3.804494,"twenty":-14.020155,"median":-5.255688,"eighty":-2.489165,"marketCap":581581547},{"date":"2024-12-06","current":-3.779243,"twenty":-14.018477,"median":-5.238596,"eighty":-2.555034,"marketCap":577721493},{"date":"2024-12-13","current":-3.434145,"twenty":-14.005323,"median":-5.210452,"eighty":-2.563675,"marketCap":524967414},{"date":"2024-12-20","current":-2.912289,"twenty":-13.971834,"median":-5.168992,"eighty":-2.592993,"marketCap":445192954},{"date":"2024-12-27","current":-4.452604,"twenty":-13.940945,"median":-5.132962,"eighty":-2.607051,"marketCap":680656280},{"date":"2025-01-03","current":-4.360017,"twenty":-13.93135,"median":-5.121166,"eighty":-2.630319,"marketCap":666502747},{"date":"2025-01-10","current":-3.939166,"twenty":-13.92256,"median":-5.100627,"eighty":-2.650133,"marketCap":602168505},{"date":"2025-01-17","current":-3.770826,"twenty":-13.894657,"median":-5.017126,"eighty":-2.697538,"marketCap":576434808},{"date":"2025-01-24","current":-3.863413,"twenty":-13.878895,"median":-4.988158,"eighty":-2.725532,"marketCap":590588341},{"date":"2025-01-31","current":-3.972834,"twenty":-13.872031,"median":-4.962243,"eighty":-2.745377,"marketCap":607315244},{"date":"2025-02-07","current":-3.594068,"twenty":-13.861735,"median":-4.906061,"eighty":-2.786001,"marketCap":549414426},{"date":"2025-02-14","current":-3.299472,"twenty":-13.861735,"median":-4.873501,"eighty":-2.815767,"marketCap":504380457},{"date":"2025-02-21","current":-3.156383,"twenty":-13.861735,"median":-4.86258,"eighty":-2.823652,"marketCap":482506815},{"date":"2025-02-28","current":-2.836536,"twenty":-13.861735,"median":-4.861298,"eighty":-2.813434,"marketCap":433612791},{"date":"2025-03-07","current":-2.491438,"twenty":-13.853814,"median":-4.8503,"eighty":-2.724226,"marketCap":380858712},{"date":"2025-03-14","current":-2.331515,"twenty":-13.82213,"median":-4.821011,"eighty":-2.652983,"marketCap":356411700},{"date":"2025-03-21","current":-2.676613,"twenty":-13.82213,"median":-4.797324,"eighty":-2.63485,"marketCap":409165779},{"date":"2025-03-28","current":-1.691821,"twenty":-13.82213,"median":-4.768576,"eighty":-2.602098,"marketCap":258623652},{"date":"2025-04-04","current":-1.512581,"twenty":-13.82006,"median":-4.749792,"eighty":-2.558775,"marketCap":224922283},{"date":"2025-04-11","current":-1.63776,"twenty":-13.805931,"median":-4.730006,"eighty":-2.526789,"marketCap":243536541},{"date":"2025-04-17","current":-1.616897,"twenty":-13.782525,"median":-4.712385,"eighty":-2.472835,"marketCap":240434164},{"date":"2025-04-25","current":-1.543876,"twenty":-13.782525,"median":-4.704656,"eighty":-2.419894,"marketCap":229575847},{"date":"2025-05-02","current":-1.470854,"twenty":-13.74292,"median":-4.683117,"eighty":-2.321199,"marketCap":218717530},{"date":"2025-05-09","current":-1.262223,"twenty":-13.74292,"median":-4.673932,"eighty":-1.691821,"marketCap":187693767},{"date":"2025-05-16","current":-3.774812,"twenty":-13.703315,"median":-4.672091,"eighty":-1.683404,"marketCap":293174562}],"updateTime":1747620382244}}}